Potential target for reducing obesity-related inflammation
16 November 2015 | By Victoria White
Investigators found that a protein called SIRT3 provides resistance to obesity-related inflammatory response...
List view / Grid view
16 November 2015 | By Victoria White
Investigators found that a protein called SIRT3 provides resistance to obesity-related inflammatory response...
10 November 2015 | By Victoria White
The initiative aims to accelerate research into biology's "invisible mass" to provide novel insights into cell function and a new frontier in drug discovery...
10 November 2015 | By Victoria White
Scientists from the University of New Mexico and NIH have created a cholesterol-lowering vaccine that leads to reductions in LDL cholesterol in mice and macaques...
20 October 2015 | By Victoria White
Domainex has been selected as Imperial’s strategic drug discovery partner to provide services including biochemical and biophysical assay development...
15 September 2015 | By Victoria White
Researchers have discovered a new gene, USP19, involved in the muscle wasting syndrome cachexia that could be a good target for drug development...
8 September 2015 | By Victoria White
AMRA will collaborate with Pfizer to help provide a better understanding of the relationship between body composition and risk for obesity related diseases...
26 August 2015 | By Victoria White
A new study will expose healthy adult volunteers to respiratory syncytial virus (RSV), a virus that causes cold-like symptoms in adults...
19 August 2015 | By Victoria White
Scientists have developed a potentially better and more accurate high-throughput screening technique and have used it to identify 24 drug candidates...
12 August 2015 | By Author: Katie Sadler, Digital Content Producer, Drug Target Review
Research carried out by University of California San Francisco (UCSF) has revealed ion channel blocking drugs could play a part in cancer therapy. The common class of channel blocking drugs, which are used to treat cardiac, neurological, and psychiatric disorders, could prove to be beneficial in cancer treatment according to…
11 August 2015 | By Katie Sadler, Digital Content Producer, Drug Target Review
Johns Hopkins researchers have identified a novel cell signalling pathway in mice through which mammals can regenerate hair and skin while healing from wounds. The discovery, summarised in an article published on 6th August in the journal Cell Stem Cell, could, they say, eventually help spur the growth of new…
20 July 2015 | By
Using existing drugs to restore basic biological processes in human cells, researchers may have devised effective treatments for mitochondrial diseases...
14 July 2015 | By Victoria White
The Francis Crick Institute and GSK are to partner up to explore new avenues of medical research and drug discovery across a broad range of diseases...
13 July 2015 | By Victoria White
Summit Therapeutics has announced the publication of preclinical data on the disease-modifying potential of utrophin modulation in the treatment of DMD...
7 July 2015 | By Victoria White
Researchers have created a first-of-its-kind animal model to pinpoint two biomarkers that are elevated in the most severe form atherosclerosis...
6 July 2015 | By Victoria White
A protein dubbed 'Bcl-Rambo' can protect against heart failure, suggests new research from King's College London and funded by the British Heart Foundation...